Session Datesort ascending
Human Oncology Journal Club -- Planning Committee Disclosure (21-22) 06/30/2022 - 11:00pm to 11:59pm CDT
Implications of Medical Board Certification Practices on Family Planning and Professional Trajectory for Early Career Female Radiation Oncologists, June 8th, 2022 06/08/2022 - 8:00am to 9:00am CDT
ECOG ACRIN 3311: Treatment De-Intensification for Low Risk HPV+ Oropharyngeal Cancer 5/17/22 05/17/2022 - 8:00am to 9:00am CDT
Multicenter, Randomized, Phase III Trial of Short-Term Radiotherapy Plus Chemotherapy Versus Long-Term Chemoradiotherapy In Locally Advanced Rectal Cancer (STELLAR), April 4th, 2022 04/04/2022 - 8:00am to 9:00am CDT
Adjuvant and concurrent temozolomide for 1p/19q non-co-deleted anaplastic glioma (CATNON; EORTC study 26053-22054): second interim analysis of a randomised, open-label, phase 3 study, March 7th, 2022 03/08/2022 - 8:00am to 9:00am CST
Abiraterone Acetate and Prednisolone with or without Enzalutamide for High-Risk Non-Metastatic Prostate Cancer, February 7th, 2022 02/07/2022 - 8:00am to 9:00am CST
Reduced-Dose and Reduced-Volume Radiotherapy With Chemotherapy for Newly Diagnosed Average-Risk Medulloblastoma, January 26, 2022 01/26/2022 - 8:00am to 9:00am CST
To RT or Not, that is the Question (for DCIS), December 6th, 2021 12/06/2021 - 8:00am to 9:00am CST
Pan-Cancer prediction of radiotherapy benefit using genomic-adjusted radiation dose (GARD): a short-based pooled analysis, Nov. 1st, 2021 11/01/2021 - 8:00am to 9:00am CDT
Postoperative Radiotherapy in Resected NSCLC - is it ever indicated? October, 4, 2021 10/04/2021 - 8:00am to 9:00am CDT